Olink-sponsored Science/AAAS webinar – now available on-demand!
Title: “Emerging liquid biopsy biomarkers: Predicting response and resistance to cancer immunotherapy” Original broadcast date: Wednesday, 9 October 2019
Speakers: Genevieve Boland, M.D., Ph.D., FACS Massachusetts General HospitalBoston, MA Evert Jan Van Limbergen, M.D., Ph.D.Maastro Clinic Maastricht, The Netherlands
During the webinar, the speakers will:
Explain how whole-plasma proteomic profiling in melanoma and non–small cell lung cancer (NSCLC) patients enables discovery of blood-based biomarkers to predict immunotherapy responses, including resistance and toxicity
Describe how changes in immune activation during immunotherapy and radiation could be tracked by differentially expressed plasma proteins